To provide an integrated offer for the preclinical development of biotherapeutics, GTP has added mammalian cell line development services to its portfolio. We can now supply a CHO stable cell line ready for transfer to GMP manufacturing.
Published on 2018-10-19 Upstream Process
The GTP team has developed CHO-based transient transfection services using an optimized in-house protocol for timely production of recombinant proteins
Published on 2018-04-05 Upstream Process
Recent advances in mammalian cell line development and discussion of the criteria a biotech company should consider when starting its cell line development process.
Published on 2017-10-02 Upstream Process
A hint: it's not only about science.
Published on 2016-09-19 Upstream Process
Pichia pastoris has some key advantages that make it a system of choice for the production of certain types of protein.
Published on 2016-02-16 Upstream Process
What you will read about: our opinion on the best system to use for production of your MAb candidates for POC studies.
Published on 2015-09-11 Upstream Process
What you will read about: Conclusions of our freedom to operate studies on P. pastoris expression system.
Published on 2015-07-07 Upstream Process
What you will read about: Conclusions of our freedom to operate studies on T7 promoter system.
Published on 2015-03-02 Upstream Process
What you will read about: our investigations after E. coli culture lysis and conclusions regarding the role of prophage DE3.